NLRP3 and dilated cardiomyopathy: A mouse model of doxorubicin-induced dilated cardiomyopathy showed similar results where knockout of the gene for NLRP3 inhibited pyroptosis and reduced the extent of doxorubicin-induced left ventricular dysfunction [73].